X-COR Therapeutics

X-COR Therapeutics is developing a low-flow extracorporeal CO2 removal device aimed at treating hypercarbic respiratory failure. This condition, which results in elevated CO2 levels in the blood, can be triggered by chronic diseases such as COPD and cystic fibrosis, as well as acute respiratory issues.